Delta Care Rx Announces New Product Line Aimed at the High Cost of Hospice Inpatient Unit Medication Management

Share Article

While many hospice pharmacy vendors serving the industry focus on mergers, acquisitions and consolidation; Delta Care Rx continues to implement their strategic business plan built around EXTREME client service, REAL business transparency, and proprietary technologies like the newly announced "Inpatient Innovations™" offering.

News Image
Delta Care Rx really understands the hospice in-patient environment of care. Our Inpatient Innovations product is evidence of our professional competence regarding hospice medication access.

In what has been a very progressive start to the second quarter of 2015 for the industry leading hospice pharmacy solution provider, Delta Care Rx released details regarding the company's newest product line known as "Inpatient Innovations™". With this new professional pharmacy service, Delta Care Rx plans to revolutionize the way the hospice industry manages medication use in the inpatient unit setting.

Dr. Mary Mihalyo, Delta Care Rx CEO, recognizes the huge potential for the hospice industry as a whole to reduce inpatient unit operating costs by taking advantage of Delta's exclusive technology and proprietary sourcing model now available to the hospice industry from coast to coast. "Delta Care Rx continues to focus on innovative solutions designed to assist the hospice industry in redesigning and improving day to day operations that will result in improved quality of care and reduced costs." Delta's proprietary Inpatient Innovations™ product improves care because it allows on-demand access to medications, including those administered intravenously, at a much reduced cost. Mihalyo commented further, stating, "Delta Care Rx really understands the hospice in-patient environment of care. Our Inpatient Innovations™ product is evidence of our professional competence regarding hospice medication access. We have strategically reinvented the wheel here as of late! Our unique and new product, along with its' associated technology will prompt valuable change opportunity for the industry in similar fashion to e-Prescribing and truly transparent/pass-through Rx purchasing models."

Delta's news about advanced inpatient procurement technologies prompting heavy discussion in the hospice space is timely as the 2015 NHPCO Management & Leadership Conference to be held at the National Harbor this week is about to begin. Delta Care Rx will be present as an exhibitor at booth #617, where the company plans to showcase its' entire hospice pharmacy offering to thousands of planned attendees.

More information about the company’s readiness to support current and prospective Hospice clients is available at http://www.DeltaCareRx.com.

Remember: “It’s neither immoral nor unethical to think about the cost of therapy.”

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Amanda K
Delta Care Rx
+1 (412) 539-9337
Email >
@DeltaCareRx
Follow >
Delta Care Rx

Follow us on
Visit website